Sonova Buys InSound, Eyes Lyric Hearing Aid Sales Of $300 Mil. By 2015

Swiss hearing aid maker Sonova expects sales of its newly acquired Lyric "invisible" hearing aid to reach $200 million to $300 million by 2015. The firm acquired Lyric developer InSound Medical on Jan. 6 for $75 million, plus milestone payments

More from Archive

More from Medtech Insight